Welcome to your 💊 Cholinergic Autonomic Pharmacology Arena
1.
A 54-year-old man with glaucoma receives pilocarpine. Which sequence best explains how this drug helps reduce intraocular pressure?
2.
A child is brought to the emergency department after ingesting an unknown number of atropine-containing tablets. He is flushed, confused, febrile, and has hot dry skin. Which mechanism is the major contributor to his elevated body temperature?
3.
A 60-year-old patient is given trimethaphan and develops both cardiovascular and gastrointestinal adverse effects. Which receptor is the principal pharmacological target responsible for these effects?
4.
A 67-year-old woman with Alzheimer disease is started on a drug that improves cholinergic transmission in the central nervous system. Which mechanism best explains its therapeutic action?
5.
A 70-year-old patient with dementia is started on a centrally acting cholinomimetic. The physician explains that the expected benefit is symptomatic rather than curative. Which drug best fits this description?
6.
A 46-year-old patient develops severe agitation, hallucinations, marked tachycardia, dilated pupils, and dry skin following excessive exposure to an antimuscarinic drug. Which agent is most appropriate when pharmacological reversal of both central and peripheral toxicity is required?
7.
A 55-year-old man with chronic obstructive pulmonary disease is prescribed an inhaled antimuscarinic. The physician prefers a drug with minimal central nervous system effects. Which pharmacokinetic property best supports this choice?
8.
A patient with excessive airway secretions requires an antimuscarinic drug before a procedure. The physician wishes to minimize central adverse effects. Which drug characteristic would be most desirable?
9.
A 70-year-old woman with known angle-closure glaucoma is mistakenly given an antimuscarinic eye preparation. Soon afterward, she develops severe ocular discomfort and worsening visual symptoms. Which drug effect most likely precipitated the problem?
10.
A patient with bradycardia is being considered for therapy with a cholinomimetic drug for another condition. Why should the drug be used with caution?
11.
A student compares atropine with a ganglion-blocking drug. Atropine produces predictable effects by reducing muscarinic responses, whereas the effects of the ganglion blocker differ among organs. Which concept best explains this difference?
12.
A patient treated with a cholinomimetic develops diarrhea, sweating, miosis, bronchospasm, and bradycardia. Which therapeutic decision is most directly supported by this pattern?
13.
During an autonomic pharmacology experiment, stimulation of a presynaptic receptor decreases further release of norepinephrine from a sympathetic nerve terminal. Which receptor best explains this negative feedback effect?
14.
A 40-year-old man receives an acetylcholinesterase inhibitor. The drug increases acetylcholine not only at parasympathetic effector organs but also at autonomic ganglia. Which receptor is stimulated at these ganglia?
15.
A patient receiving excessive anticholinesterase therapy develops generalized weakness together with salivation, diarrhea, miosis, and bradycardia. The weakness is most appropriately explained by excessive acetylcholine acting at which site?
16.
A 24-year-old woman receives an antimuscarinic eye drop before refraction testing. She subsequently reports difficulty reading a nearby text despite being able to see distant objects. Which physiological change most directly accounts for this complaint?
17.
A researcher administers a drug that blocks neuronal nicotinic receptors in both sympathetic and parasympathetic ganglia. Which change is most likely in the gastrointestinal tract?
18.
A 45-year-old woman with postoperative urinary retention is considered for treatment with bethanechol. Before prescribing the drug, which additional finding would most strongly argue against its use?
19.
During ophthalmic examination, a physician wants rapid pupillary dilatation that will wear off relatively quickly after the procedure. Which antimuscarinic is most appropriate?
20.
A patient receiving a ganglion-blocking drug develops marked dizziness immediately after standing. His blood pressure falls substantially in the upright position. Loss of which physiological mechanism is primarily responsible?
21.
A sympathetic postganglionic nerve terminal is exposed to a neurotransmitter released from a nearby parasympathetic fiber. The transmitter binds to a presynaptic receptor and alters norepinephrine release. This receptor is best classified as a:
22.
A researcher studies two reversible acetylcholinesterase inhibitors. Drug A readily enters the central nervous system, while Drug B acts mainly peripherally because it crosses the blood-brain barrier poorly. Which drug is most consistent with Drug A?
23.
A 36-year-old woman with myasthenia gravis develops worsening muscle weakness while receiving anticholinesterase therapy. In the classical use of edrophonium, her muscle strength improves transiently after administration. Which interpretation is most appropriate?
24.
A drug produces increased gastrointestinal motility, increased glandular secretion, miosis, and detrusor contraction. Which receptor distribution best accounts for this pattern?
25.
A 64-year-old man with chronic obstructive pulmonary disease is prescribed tiotropium. His breathing improves with little sedation or confusion. Which combination best explains the therapeutic advantage of this drug?
26.
A drug causes increased contractile force of the myocardium without directly referring to changes in heart rate or AV conduction. Which cardiovascular term best describes this effect?
27.
A 58-year-old man receives a drug that increases acetylcholine at autonomic synapses by inhibiting its breakdown. Soon afterward, he develops sweating, abdominal cramps, increased salivation, and bradycardia. Which receptor type is primarily responsible for most of these manifestations?
28.
A 19-year-old student takes a medication for motion sickness before a long journey. He becomes mildly drowsy but does not vomit during travel. Which characteristic of the drug is most important for both effects?
29.
A ganglion-blocking drug produces tachycardia in a resting healthy adult. Which principle best explains this response?
30.
A pharmacology student compares two cholinomimetics. Drug X directly binds to muscarinic receptors, while Drug Y increases acetylcholine concentration at both muscarinic and nicotinic synapses. Which classification best describes Drug Y?
31.
A patient receives a direct-acting cholinomimetic that is relatively resistant to hydrolysis by acetylcholinesterase. Compared with acetylcholine, which pharmacological property would be expected?
32.
A 62-year-old man develops marked slowing of atrioventricular conduction after receiving a muscarinic agonist. Which change in cardiac function is being demonstrated?
33.
A patient with obstructive airway disease is mistakenly given a potent muscarinic agonist. He develops respiratory difficulty shortly afterward. Which combination best explains the worsening of his symptoms?
34.
A 72-year-old man with urinary hesitancy due to prostatic enlargement is accidentally prescribed a potent antimuscarinic drug. Several hours later, he develops painful lower abdominal distension and inability to void. Which action most likely precipitated this complication?
35.
A patient exposed to an acetylcholinesterase inhibitor develops profuse bronchial secretions, wheezing, and bradycardia. Atropine improves these manifestations but muscle weakness persists. Which explanation best accounts for this difference?
36.
A 59-year-old man receives a ganglion-blocking agent during a procedure requiring reduction of vascular sympathetic tone. Soon afterward, he develops hypotension, dry mouth, blurred vision, constipation, and urinary retention. Which feature of ganglion blockade best explains the wide range of adverse effects?
37.
A 66-year-old patient receives atropine for excessive vagal slowing of the heart. His pulse rate increases without direct stimulation of cardiac adrenergic receptors. Which sequence best explains this response?
38.
A cholinomimetic drug increases smooth muscle contraction in the urinary bladder but has little direct effect on skeletal muscle. Which receptor selectivity most likely explains this difference?
39.
A 68-year-old man receiving treatment for symptomatic bradycardia develops dry mouth, blurred near vision, and difficulty passing urine after administration of atropine. Which single pharmacological property best explains the combination of these findings?
40.
A new autonomic drug causes vasodilation with postural hypotension, tachycardia, reduced gut motility, urinary retention, and impaired accommodation. The drug has no direct action on muscarinic receptors at effector organs. Which drug class best fits this pharmacological profile?
